Gil Leibowitz
Impact in
- Epidemiology top 0.5%
- Autophagy in Disease and Therapy
- Aging top 2%
Papers in
- Surgery 33
- Pancreatic function and diabetes 31
- Epidemiology 11
- Autophagy in Disease and Therapy 11
- Co-authors
- Erol Cerasi (27 shared papers)Nurit Kaiser (11 shared papers)Ν. Kaiser (10 shared papers)Yafa Ariav (7 shared papers)Etty Bachar-Wikström (6 shared papers)Mali Ketzinel‐Gilad (4 shared papers)Fred Levine (4 shared papers)Jakob D. Wikström (5 shared papers)
- Journals
- Diabetologia (8 papers)Diabetes (7 papers)Endocrinology (4 papers)PLoS ONE (2 papers)Clinical Endocrinology (2 papers)
- Partner nations
- IsraelUnited StatesSweden
In The Last Decade
Gil Leibowitz
54 papers receiving 7.8k citations
Gil Leibowitz's Hit Papers
Peers
Comparison fields: 5 of 128
- Epidemiology 2.9k
- Aging 100
- Surgery 1.4k
- Cell Biology 369
- Endocrinology, Diabetes and Metabolism 402
Countries citing papers authored by Gil Leibowitz
This map shows the geographic impact of Gil Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Leibowitz more than expected).
Fields of papers citing papers by Gil Leibowitz
This network shows the impact of papers produced by Gil Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Leibowitz. The network helps show where Gil Leibowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Gil Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Hit paper breakdown → | 2016 | 4680 |
| 2 | 2008 | 330 | |
| 3 | 2003 | 178 | |
| 4 | 2012 | 177 | |
| 5 | 1999 | 170 | |
| 6 | 2017 | 166 | |
| 7 | 1996 | 153 | |
| 8 | 1999 | 150 | |
| 9 | 1999 | 150 | |
| 10 | 1995 | 134 | |
| 11 | 2009 | 128 | |
| 12 | 2016 | 128 | |
| 13 | 1999 | 126 | |
| 14 | 2013 | 107 | |
| 15 | 2014 | 83 | |
| 16 | 2016 | 67 | |
| 17 | 2017 | 67 | |
| 18 | 2008 | 66 | |
| 19 | 2001 | 63 | |
| 20 | 2013 | 55 |
About Gil Leibowitz
Gil Leibowitz is a scholar working on Surgery, Epidemiology, Cell Biology, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 55 papers that have together received 7.9k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (31 papers), Autophagy in Disease and Therapy (11 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Chronic Kidney Disease and Diabetes (3 papers), Mitochondrial Function and Pathology (3 papers), Alzheimer's disease research and treatments (2 papers), Pituitary Gland Disorders and Treatments (2 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Epidemiology (2.9k citations), Aging (100 citations), Surgery (1.4k citations), Cell Biology (369 citations) and Endocrinology, Diabetes and Metabolism (402 citations). Gil Leibowitz has collaborated with scholars based in Israel, United States and Sweden. Frequent co-authors include Erol Cerasi, Nurit Kaiser, Ν. Kaiser, Yafa Ariav, Etty Bachar-Wikström, Mali Ketzinel‐Gilad, Fred Levine, Jakob D. Wikström, Rafael Nesher and David E. Kang. Their work appears in journals such as Diabetologia, Diabetes, Endocrinology, PLoS ONE and Clinical Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.